Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
Clinical trial NCT00629499 · COMPLETED
Trial details
- NCT number
- NCT00629499
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.